Cargando…

Cardiovascular risk stratification in familial hypercholesterolaemia

Familial hypercholesterolaemia (FH) is a common autosomal-dominant disorder in most European countries. Patients with FH are characterised by a raised level of low-density lipoprotein cholesterol and a high risk of premature coronary heart disease (CHD). Currently there is no consensus regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharifi, Mahtab, Rakhit, Roby D, Humphries, Steve E, Nair, Devaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941166/ https://www.ncbi.nlm.nih.gov/pubmed/27126396 http://dx.doi.org/10.1136/heartjnl-2015-308845

Ejemplares similares

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
por: Ramaswami, Uma, et al.
Publicado: (2017)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care
por: Jones, Matthew, et al.
Publicado: (2022)

Case-finding and genetic testing for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
por: Futema, Marta, et al.
Publicado: (2014)

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
por: Futema, Marta, et al.
Publicado: (2012)

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
por: Humphries, Steve E., et al.
Publicado: (2018)

Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia
por: Khamis, Amna, et al.
Publicado: (2015)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Futema, Marta, et al.
Publicado: (2017)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
por: Capra, Maria Elena, et al.
Publicado: (2023)

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
por: Wiegman, Albert, et al.
Publicado: (2015)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study
por: Seed, Mary, et al.
Publicado: (2012)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
por: Blom, Dirk J., et al.
Publicado: (2018)

Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia
por: Khan, Tina Z, et al.
Publicado: (2020)

Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse‐led clinics
por: Green, Peter, et al.
Publicado: (2015)

Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review
por: Mansilla-Rodríguez, María Elena, et al.
Publicado: (2023)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
por: Humphries, Steve E., et al.
Publicado: (2019)

Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records
por: Iyen, Barbara, et al.
Publicado: (2020)

LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
por: Al-Allaf, Faisal A, et al.
Publicado: (2010)

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
por: Pećin, Ivan, et al.
Publicado: (2017)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
por: Neil, Andrew, et al.
Publicado: (2008)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Systematic Identification of Familial Hypercholesterolaemia in Primary Care—A Systematic Review
por: Silva, Luisa, et al.
Publicado: (2021)

Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study
por: Venuraju, Shreenidhi M., et al.
Publicado: (2019)

Nutraceuticals in hypercholesterolaemia: an overview
por: Santini, Antonello, et al.
Publicado: (2016)

Reducing cardiovascular disease risk among families with familial hypercholesterolaemia by improving diet and physical activity: a randomised controlled feasibility trial
por: Kinnear, Fiona Jane, et al.
Publicado: (2020)

Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia
por: Anagnostopoulou, Katherine K, et al.
Publicado: (2009)

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
por: Ramaswami, Uma, et al.
Publicado: (2020)

Familial hypercholesterolaemia in South Africans: tracking findings and developments over time
por: Delport, Rhena
Publicado: (2009)

A perspective for sequencing familial hypercholesterolaemia in African Americans
por: Wright, Michelle L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cjuugp2ohthh5bfpgis2srfhdn